THOMPSON DAVIS & CO., INC. - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 175 filers reported holding IMMUNOMEDICS INC in Q1 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.

Quarter-by-quarter ownership
THOMPSON DAVIS & CO., INC. ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2018$16,000
-11.1%
7500.0%0.04%
-18.6%
Q2 2018$18,000
+63.6%
7500.0%0.04%
+48.3%
Q1 2018$11,000
-8.3%
7500.0%0.03%
+3.6%
Q4 2017$12,000
+71.4%
750
+50.0%
0.03%
+133.3%
Q3 2017$7,0000.0%500
-33.3%
0.01%
+9.1%
Q2 2017$7,0007500.01%
Other shareholders
IMMUNOMEDICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 10,488,076$92,610,00011.69%
First Light Asset Management, LLC 2,048,643$18,090,0006.07%
Foresite Capital Management III, LLC 1,940,850$17,138,0005.60%
DAFNA Capital Management LLC 637,700$5,631,0004.02%
ACUTA CAPITAL PARTNERS, LLC 1,600,000$14,128,0003.95%
Opaleye Management Inc. 900,000$7,947,0003.32%
Ghost Tree Capital, LLC 1,200,000$10,596,0002.20%
Iguana Healthcare Management, LLC 325,000$2,870,0001.62%
Healthcare Value Capital, LLC 100,000$883,0001.59%
Palo Alto Investors LP 3,010,466$26,582,0001.24%
View complete list of IMMUNOMEDICS INC shareholders